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Innate immunityThe mucosal lining forms the physical and chemical barrier that protects against pathogens and
hostile particles and harbors its own population of bacteria, fungi and archea, known as the micro-
biota. The immune system controls tolerance of this population of microorganisms that have proven
to be beneﬁcial for its host. Keeping its physical integrity and a correct balance with the microbiota,
the mucosa preserves its homeostasis and its protective function and maintains host’s health.
However, in some conditions, pathogens may succeed in breaching mucosal homeostasis and suc-
cessfully infecting the host. In this review we will discuss the role the mucosa plays in the defense
against bacterial pathogens by considering the gap junction protein connexins. We will detail their
implication in mucosal homeostasis and upon infection with bacteria in the respiratory and the
gastrointestinal tracts.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The mucosal lining, composed of a stage of epithelial cells on
top of a stage of connective tissue bearing the mucosa’s vascula-
ture, forms an exchange interface as well as a defense barrier
between the exterior environment and the interior milieu of the
mammalian body. The mucosa is colonized by a group of microor-
ganisms, named the microbiota that live in symbiosis with host
and provide protection against pathogenic microbes [1]. Further-
more, keeping an architectural integrity is a main aspect in main-
taining mucosal homeostasis. This integrity is partly regulated by
membrane proteins forming structures such as tight junctions,
adherens junctions or gap junctions [2]. Gap junctions provide
direct cell-to-cell communication between the different cells
constituting the epithelial barrier. This communication is mediated
by connexin (Cx) channels that ensure direct physical link between
cells in a tissue. In addition, Cx channels can also mediate paracrine
communication between cells. The modulations of these proteins
by pathogens and bacterial toxins has been reviewed by Ceelen
and colleagues in 2011 [3]. In this work, we will focus on how these
channels can either facilitate infection or, on the contrary, amelio-
rate host defense and arrest pathogen spreading in the airways’and gut’s mucosae. For that purpose, we will detail the mecha-
nisms by which the respiratory and the gastrointestinal mucosae
exert their protective role against pathogens according to their
respective structures and functions.
2. Connexin- and pannexin-dependent mucosal
communication
Direct cell-to-cell communication is essential in coordinating
tissue function and homeostasis. This communication, known as
gap junction intercellular communication (GJIC), is mediated by
gap junction channels that directly connect the cytoplasm of adja-
cent cells. Gap junction channels are made up of the membrane
protein connexins (Cxs). The human Cx family comprises 21
members, with Cx43 being the most frequently expressed in tis-
sues. Six Cxs form a connexon (also called a hemichannel). Connex-
ons of both cells can align and dock to form a gap junction channel
that confers a continuous link between the cytoplasm of both cells
[4]. They allow for the passage of inorganic ions and of small water
soluble molecules; thus, coupling the cells both electrically and
metabolically [4]. In addition, connexons were shown to provide
communication pathways for small molecules between the intra-
cellular and extracellular environments. Studies over the years
have shown that Cx hemichannels communicate with the external
cellular environments and have crucial effects on physiological
balance [5,6].
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putative gap junction forming molecules [7]. The human genome
codes for 3 Panxs, Panx1 being described as ubiquitously expressed
[8]. Further investigation has shown that, despite the fact that
Panxs lack homology, they are similar to Cxs at the level of struc-
ture and function [9]. However, their ability to form intercellular
channels in vivo is yet to be demonstrated. The accepted notion
is that they form membrane channels known as pannexons [10–
12]. Due to the close analogy of Cx and Panx, it is difﬁcult to discuss
Cx without evoking the Panx, especially when investigating chan-
nel function and formation that cannot clearly differentiate the
implication of these two families in observed phenomena [13].
For instance, connexons have been proposed as a putative channel
for ATP release (and so have pannexons), and if the characteristics
of these two types of channels suggest that pannexons are better
candidates, both channels remain studied as ATP-releasing chan-
nels [14]. Moreover, due to the similarity in structure and function
with Cx, Panx were shown to be blocked by gap junction inhibitors.
In this context, assays to study the activity of Cx and Panx1 chan-
nels often use the same inhibitors, though at different concentra-
tions [15,16]. Therefore, we will review the relevant roles of Cxs
along with Panxs in host–pathogen interaction in the mucosae of
the airways and the gastrointestinal tract.
3. Mucosal structures and functions
3.1. The respiratory mucosa
The human upper respiratory tract is formed of a pseudostrati-
ﬁed epithelium composed of basal cells, ciliated epithelial cells and
non-ciliated, mucus-producing cells that maintain the airway
homeostasis [17]. The secreted mucus layer acts as a physical
and chemical trap to pathogens and is subjected to continuous mo-
tion from the cilia beating; a phenomenon known as mucociliary
clearance [18,19]. Recent studies evidenced the presence of a respi-
ratory tract microbiota; however, its role in maintaining homeo-
stasis is still emerging [20]. Being the ﬁrst line of defense against
inhaled hostile particles, the airway epithelium is in constant risk
of injury and hence it maintains its integrity by a continuous repair
process which eventually restores the well-differentiated epithe-
lium [21,22]. Further downwards in the respiratory tree, the muco-
sa shows a different morphology and composition. In the alveoli,
the epithelial lining is comprised of alveolar type I (ATI) and type
II (ATII) epithelial cells. ATI cells cover most of alveolar lumen sur-
face and provide the bulk of the lumen surface for gas exchange,
whereas ATII cells secrete surfactant, which is a major determinant
of alveolar patency [23]. Alveoli are embedded in a network of cap-
illary endothelial cells allowing gas exchange with the blood circu-
lation. This close proximity with the blood circulation also allows
prompt immune cell recruitment upon pathogen infection [24].
3.2. The gastrointestinal mucosa
The stomach and intestines form part of the gastrointestinal
tract. The gastric mucosa is composed of a tight epithelial barrier
and is covered by a layer made of secreted mucus. The secretion
of gastric epithelial cells creates an acidic pH in the lumen, which
is an important defense mechanism against pathogens. The epithe-
lial cells are protected from this pH by the production of HCO3 in
the mucus layer [25].
The intestinal mucosa is formed of a single layer of specialized
epithelial cells and of goblet cells [26]. Enterocytes in the small
intestine and in the colon are specialized in ion, sugar and amino
acid transport while goblet cells produce a protective mucous
layer. Depending of the segment of the gut, other cell types, mostlyendocrine, can be found. The microbiota plays a beneﬁcial role in
maintaining the intestinal homeostasis mainly by preventing the
growth of pathogenic microorganisms, aiding in digestion and pro-
viding vitamins [27]. Finally, the repair mechanism of the small
intestine has been widely described and is crucial to seal the brea-
ched area upon injury [26].
4. Mucosal immunity and tolerance
Being at the interface with the outside environment, the muco-
sal immunity has a complex task of controlling the balance be-
tween tolerance of the beneﬁcial microbiota and inducing innate
responses against pathogens [1,27]. The immune system recog-
nizes pathogen-associated molecular patterns (PAMPs) through
pathogen recognition receptors (PRRs) expressed on host’s cells.
Upon reaction with PAMPs, PRRs activate speciﬁc signaling path-
ways that lead to antipathogenic effects. PRRs include, among oth-
ers, toll-like receptors (TLRs) and nucleotide-binding and
oligomerization domain (NOD)-like receptors (NLRs) [28]. While
NLRs are exclusively intracellular PRRs, TLRs are transmembrane
proteins that can be expressed either on the cell surface or in intra-
cellular compartments [29]. Depending on their subfamily, TLRs
recognize speciﬁc extracellular and intracellular PAMPs, and hence
activate the appropriate signaling cascade to eliminate the patho-
gen. For example, surface TLR2, TLR4 and TLR5 recognize extracel-
lular bacterial cell wall glycoproteins, lipopolysaccharide (LPS) and
ﬂagellin, respectively; whereas endosomal TLR7, TLR8 and TLR9
recognize internalized nucleic acids [28]. Once TLRs are activated,
adaptor proteins are recruited to the TLR’s cytoplasmic domain
[29]. This recruitment activated signaling pathways, such as mito-
gen-activated protein kinases (MAPKs), and transcription factors
such as nuclear factor (NF)-jB, to initiate an inﬂammatory re-
sponse characterized by the production of pro-inﬂammatory cyto-
kines and chemokines, and by apoptosis [30,31].
5. Connexins in mucosal defense of the respiratory tract
5.1. Ciliary beating and surfactant secretion
A growing body of evidence shows that Cxs and Panxs regulate
mucociliary clearance and surfactant secretion by coordinating cil-
iary beating, airway surface liquid (ASL) volume and mucus secre-
tion. Ciliary beating was shown to be coordinated in a gap
junction-dependent mechanism. Indeed, early studies demon-
strated that gap junctions regulate beat frequency in airway cells
[32]. Later, it was suggested that the propagation of IP3 through
Cx channels mediates Ca2+ waves propagation between airway epi-
thelial cells to coordinate ciliary beating [33]. More recent studies
suggest another mechanism of Cx- or Panx-mediated coordination
of ciliary beating along the epithelium. It was shown that ATP re-
lease to the extracellular environment induced Ca2+ signaling in
epithelial cells due to type-2 purinergic receptors (P2R) activation
in a paracrine fashion [34]. Recently, the release of ATP induced by
mechanical stress was found to correlate with functional expres-
sion of Panx1 channels in differentiated human airway epithelial
cells, as well as in murine airway tissues where Panx1 knockout
mice showed impaired ATP release [35,36]. Panx1-mediated ATP
release was also shown to be involved in regulating ciliary beating
and mucin secretion [37].
Efﬁcient mucociliary clearance requires a well-hydrated
mucous layer [18]. A recent study conducted on the airway epithe-
lial cell line Calu-3 revealed the importance of Cxs in regulating
ASL volume [38]. The inhibition of gap junction-made of Cx43 with
mimetic blocking peptides or with pharmacological inhibitors
prevented the activation of a signaling network leading to
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These results, which were conﬁrmed in human primary airway
epithelial cells after pharmacological inhibition of GJIC [38], sug-
gest that GJIC coordinates a complex signaling cascade which leads
to increase in ASL volume.
In alveoli, surfactant secretion by ATII cells is the main determi-
nant for alveolar patency by the exocytosis of lamellar bodies, a
type of phospholipid-rich organelles [23]. This exocytosis is trig-
gered by an increase in cytosolic Ca2+. A study conducted on iso-
lated intact rat alveoli tested whether this cytosolic Ca2+ increase
was mediated by Cx channels [39]. To this end, photo-excited re-
lease of caged Ca2+ inside the cells was performed. This led to an
increase of Ca2+ concentration in the cytosol of selected alveoli as
well as neighboring ones, and induced ATII cell secretion, even
when photo-excited cells were ATI cells. These observations sug-
gest the existence of interalveolar communication involving ATI
and ATII cells, which was blocked by Cx43 inhibitory peptides;
hence, arguing that interalveolar Ca2+ signaling is regulated by GJIC
between ATI and ATII cells and mediates ATII surfactant secretion
[39].
Altogether, these reports show an important role for Cxs and
Panxs in maintaining the respiratory mucosal homeostasis and
sustaining mechanisms essential for mucosal defense. In the fol-
lowing paragraph we will discuss how Cxs contribute in pathogen
clearing by their interaction with components of the immune
system.
5.2. Pathogen-induced airway mucosa innate immune responses
Pseudomonas aeruginosa, a versatile Gram-negative bacterium
able to infect damaged tissues or those with reduced immunity,
cause generalized inﬂammation and sepsis [40]. Although P. aeru-
ginosa is readily cleared in the airways of healthy subjects, it can
cause acute lung infections in intubated patients or chronic lung
infections in Cystic Fibrosis (CF) patients [40]. CF, a congenital de-
fect due to mutations in the cystic ﬁbrosis transmembrane conduc-
tance regulator (CFTR) gene, is characterized by excessive and
destructive airway inﬂammation [41].
In this context, an in vitro study showed that Cx43 expression
was decreased in human epithelial cells isolated from nasal polyps
exposed to P. aeruginosa LPS for 24 h [42]. The authors suggested
that reduced GJIC may lead to decreased intercellular passage of
signaling molecules important to coordinate cellular functions,
such as ciliary beating. Other studies performed on nasal and bron-
chial airway epithelial cell lines showed that pro-inﬂammatory
molecules such as LPS, TNF-a and lysophosphatidic acid all re-
duced GJIC within 15 min by a mechanism involving the tyrosine
kinase c-Src and its direct interaction with the C-terminus of
Cx43 [43,44]. These results indicate that acute closure of gap junc-
tion channels by pro-inﬂammatory mediators precede their disap-
pearance from airway epithelial cells subjected to longer exposure.
This rapid channel gating regulation, however, was defective in CF
airway epithelial cells due to lack of c-Src activation [44]. Whether
LPS and other mediators affected the expression of Cx43 under
more chronic conditions was, however, not evaluated in these
studies.
A body of evidence described the role of Cxs in mediating efﬁ-
cient inﬂammatory responses. A study reported that TLR2 activa-
tion triggers intracellular Ca2+ waves that are transmitted
between airway epithelial cells through Cx43 channels [45]. More-
over, cytosolic Ca2+ rise activates downstream inﬂammatory sig-
nals, thereby increasing the production and release of
interleukin-8 (IL-8), a powerful chemoattractant for neutrophils
leading to their recruitment to the infected area. Interestingly,
recruitment of neutrophils in the lung of mice infected with P.
aeruginosa was signiﬁcantly inhibited by the intraperitonealadministration of a pharmacological blocker of gap junctions
[45]. In agreement with other studies [43,46], the authors observed
in vitro that bacterial stimulation induced tyrosine phosphoryla-
tion of Cx43, its association with c-Src and decrease in GJIC 4 h post
stimulation, suggesting a delayed negative regulation of gap junc-
tion channel activity. In light with these results, GJIC may therefore
represent a mechanism to recruit unstimulated cells to secrete pro-
inﬂammatory mediators; this ampliﬁcation, however, is regulated
by a negative feed-back elicited by the pro-inﬂammatory media-
tors. In CF airway epithelial cells, this negative feed-back does
not occur, which may contribute to the severity of the disease
[43,46].
Another level of interaction between Cxs and the inﬂammatory
response to bacteria can be found in the lower respiratory tract.
Two pulmonary Cxs, Cx40 and Cx43, have been described in the
lung’s microvasculature and show opposite expression patterns
during acute lung injury [47]. An earlier study showed that Cx40
is decreased after intranasal instillation of LPS from Escherichia coli
[48]. Although this study failed to reveal an effect of Cx40 deﬁ-
ciency in lung inﬂammation of Cx40/ mice, Chadjichristos and
colleagues observed enhanced recruitment of neutrophils to the
airways after intratracheal instillation of LPS from P. aeruginosa
in mice lacking Cx40 speciﬁcally in endothelial cells [49]. This ef-
fect was associated with a decreased expression and activity of
ecto-50-nucleotidase (CD73), an enzyme that hydrolyzes extracel-
lular adenine nucleotides into adenosine. After its production,
adenosine activates receptors such as the adenosine receptor
A2B. It was shown that upon A2B receptor activation, leukocyte
adhesion to endothelial cells was markedly prevented. Interest-
ingly, targeting Cx40 reduced GJIC and CD73 activity, resulting in
enhanced adhesion of neutrophils to endothelial cells, suggesting
that Cx40-dependent regulation of CD73 modulates leukocyte
transmigration across the alveolar endothelium [49].
In contrast to Cx40, which is decreased, intratracheal instilla-
tion of P. aeruginosa LPS increased Cx43 expression in mouse lung
alveolar septa [50]. In this study, Cx43+/ mice showed nearly 50%
fewer neutrophils recruited to the alveolar space after induction of
lung inﬂammation. Mice expressing a truncated form of Cx43 lack-
ing most of the C-terminus (Cx43K258stop) had increased neutrophil
recruitment in response to instillation of LPS [50]. Since gap junc-
tions containing Cx43K258stop have increased open probability and
decreased gating [51], then a role for channel function in neutro-
phil recruitment rather than a channel-independent role for
Cx43, is suggested. Consistent with this model, speciﬁc Cx43 block-
ing peptides reduced adhesion of neutrophils to the surface of
mouse alveolar and endothelial cell lines [50]. Parthasarathi and
colleagues demonstrated a spread of Ca2+ signaling through Cx43
gap junctions in alveolar arterioles of the lung capillary bed [52].
Interestingly, Ca2+ signaling was involved in the exocytosis from
endothelial cells of P-selectin, a molecule promoting leukocytes
recruitment on vascular surface [53]. Altogether, these results sug-
gest a balance between the anti-inﬂammatory Cx40 and pro-
inﬂammatory Cx43, allowing the immune system to limit tissue
damages while defending against pathogens.
5.3. Apoptosis and bacterial clearance
Apoptosis has a key role in maintaining homeostasis. On the
one hand, apoptosis, in balance with cell proliferation, regulates
the different cell populations of the mucosa [31]. On the other
hand, apoptotic cells need to be found and cleared; a mechanism
that if defected, leads to pathology [54]. In this context, Cx chan-
nels were shown to be involved in the spreading of apoptotic sig-
nals. As described in HeLa cells transfected with Cx43, Cx40 and
Cx37, apoptotic signal induced by the antitumor antibiotic strep-
tonigrin was spread via gap junctions, and apoptosis induction
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icant effect [55]. Apoptosis of airway epithelial cells is an impor-
tant mechanism for bacterial clearance by the host [56], and for
the stimulation of tissue repair [54]. This argument is further sup-
ported by reports demonstrating that mucosal macrophages in-
duce apoptosis in target cells when bacterial infection persists, as
a means of bacterial killing [57]. In this context, we found, in the
Calu-3 cells, that Cx43 mediates apoptosis after P. aeruginosa infec-
tion [58]. Indeed, Cx43 expression was up-regulated in response to
P. aeruginosa infection, an effect that was not observed in cells in-
fected with a mutant bacterium lacking ﬂagellin, the TLR5 PAMP.
Apoptosis was increased in the presence of a JNK inhibitor but
the latter effect was prevented by lentiviral expression of a Cx43-
speciﬁc shRNA. Interestingly, Cx43 expression and apoptosis was
dependent on CFTR. Thus, pharmacological inhibition of CFTR re-
duced the extent of Cx43 expression and induction of apoptosis,
an effect that involved enhanced activation of the JNK MAPK. Con-
versely, correction of the phenotype in a CF airway cell line by
adenoviral expression of wild-type CFTR restored normal JNK
activity in response to P. aeruginosa infection [58]. Thus, abnormal
regulation of Cx43 in CF airway epithelial cells may contribute to
the reduced apoptosis and bacterial killing that is observed in this
disease [59,60].
P. aeruginosa can also counteract and evade the host immune
system by producing quorum sensing molecules, such as N-3-
oxo-dodecanoyl-L-homoserine lactone C12, to coordinate bacterial
behavior and particularly production of virulence factors, depend-
ing on bacterial density [61]. Studies conducted in our laboratory
have shown that C12 disrupted epithelial gap junctions in non-
polarized airway epithelial cells [62]. This was accompanied by cell
shrinkage and blebbing, the ﬁrst signs of apoptosis. Interestingly,
these effects of C12 were not observed in polarized epithelial cells
cultured at the air–liquid interface. Under these conditions the
polarized cells were able to inactivate C12 and protect themselves
from apoptosis. These results suggest that loss of airway epithelial
cell integrity, which is the case during acute and chronic infection,
impairs C12 degradation, and thus defense of the epithelium to the
quorum-sensing molecule, providing an additional mechanism for
P. aeruginosa invasion [62].
The link between Cx43, apoptosis and bacterial killing is, how-
ever, not clear. Of note, opening of Panx1 channels in apoptotic
cells via cytoplasmic terminal cleavage by caspases was shown to
release nucleotides that act as chemoattractants for phagocytes;
therefore, providing a mechanism for clearance of dying cells
[63]. It would be possible that this apoptotic ‘‘ﬁnd-me’’ signal
mechanism applies to apoptotic airway mucosal cells. Further
studies evaluating this possibility could prove useful in the future.
6. Connexins in mucosal defense of the gastrointestinal tract
6.1. Helicobacter pylori infection and gastrointestinal-associated
diseases
The Gram-negative pathogen Helicobacter pylori is able to adapt
to the acid environment of the stomach [64]. Persistent coloniza-
tion of this pathogen is responsible for gastritis that can develop
into gastric ulcers. Apoptosis and cell proliferation are central
mechanisms of ulcers, as these lesions are characterized by dead
tissue and disorganized repair. Furthermore, H. pylori-induced gas-
tritis is a potential risk factor for gastric cancer [64].
H. pylori actively manipulates host tissues and successfully col-
onizes the gastric mucosa through the activity of several secreted
toxins. The vacuolating cytotoxin A (VacA) is a multifunctional
pore-forming toxin that disrupts cell polarity and promotes apop-
tosis of epithelial cells via cytochrome c release from mitochondria[65]. Interestingly, an implication of Cx43 in VacA-induced cell
death was found by Radin and colleagues [66]. Using insertional
mutagenesis by gene trap and shRNA strategies against Cx43 in hu-
man gastric epithelial cells, the authors demonstrated, in viability
assays, that inhibition of Cx43 expression resulted in resistance
to VacA-induced cell death. Conversely, HeLa cells exogenously
expressing Cx43 became more susceptible to VacA, indicating that
the level of expression of Cx43 contributed to apoptosis induced by
the toxin. Although the precise mechanism remains to be eluci-
dated, VacA-mediated death of gastric epithelial cells through a
Cx43-dependent pathway may be particularly important for the
persistence of H. pylori infection and in the pathogenesis of the
associated gastric ulcers. Moreover, the authors speculated that tis-
sue damages and disorganized repair, characterizing this patholog-
ical setting, might favor proliferation of cells that exhibit decreased
expression of Cx43, and such cells may have increased potential for
malignant transformation [66].
Uncontrolled cell proliferation is the basis of carcinogenesis,
and gap junctions may control cell growth by maintaining critical
signals at equilibrium between connected cells, an ability that is
reduced in most tumor cells [67]. Interestingly, decreased GJIC
was found in cultured human gastric cancer cells infected with
H. pylori [68]. In addition, decreased expression of Cx43 was ob-
served after infection with the same bacterium in another human
gastric cancer cell type [69], as well as in precancerous gastric le-
sions of patients colonized by H. pylori [70]. In all studies, down-
regulation of Cxs was associated with alteration of cell
proliferation [68–70]. Finally, in a clinical study, a correlation
was found between the occurrence of H. pylori-associated gastric
cancers and a polymorphism of Cx37 (Cx37 C1019T) [71]. Jing
and colleagues reported in the Chinese population that the risk
of H. pylori-induced gastric cancer increased signiﬁcantly for CC
and CT genotypes compared to TT genotype as compared to pa-
tients with chronic superﬁcial gastritis that were chosen as control
group [71]. This polymorphism, resulting in the non-conservative
amino acid change P319S in the C-terminus of Cx37, has been pre-
viously associated with different diseases [72]. The clinical study
by Jing and colleagues reinforced the widely observed growth sup-
pressive role of Cx37 [73,74], and extended this role in the context
of H. pylori-induced gastric cancers. Altogether, there is a relation-
ship between Cxs and H. pylori-induced diseases, whereby Cx37
appears to be protective for the host in regard to cancer, while
Cx43 seem to be targeted by the bacterium for pathogeny.
6.2. Infection-induced diarrhea
Diarrhea is a pathology accompanied by a profuse loss of water
from the intestine, which could cause severe illness, especially in
children, and is a common cause of death in developing countries.
Water release, triggered in colonic cells by stimuli such as ATP, is a
defense mechanism supposed to wipe out pathogens from the gut.
As putative ATP-releasing channels, pannexons might be involved
in this mechanism. Recently, Panx1 has been identiﬁed by immu-
nohistochemistry in epithelial and goblet cells of human colon
biopsies [75], but its functional role in the intestinal mucosa still
remains unknown.
Excessive water loss and diarrhea can occur in case of severe
infection by Gram-negative pathogenic bacteria such as Shigella
ﬂexneri, Yersinia enterocolitica, Salmonella enterica serovar
Typhimurium and Enteropathogenic E. coli (EPEC) [76]. Diarrhea in-
duced by Citrobacter rodentium is used as a mouse model for EPEC
infection in humans as this bacterium shares a lot of similarities
with EPEC. Interestingly, increased Cx43 expression and Cx43
hemichannel activity was observed in the colon of mice infected
with C. rodentium. Furthermore, mice heterozygous for Cx43 were
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The authors suggested that release of ions through Cx43 hemi-
channels could create an osmotic gradient for water secretion.
Alternatively, excess release of ATP can also contribute to water
loss. As demonstrated in rabbit colonic tissues exposed to the
supernatant of colonocytes infected with EPEC, EPEC-induced ATP
release from these cells triggered chloride efﬂux followed by water
secretion [78]. Recent observations suggest that EPEC infection in-
volves Cx hemichannels since ATP release by polarized human
intestinal cells could be inhibited with pharmacological Cx hemi-
channel blockers [79]. Similar results were obtained in response
to S. ﬂexneri and S. Typhimurium infection.
6.3. Bacterial infection via hemichannel exploitation
S. ﬂexneri and Y. enterocolitica exhibit an invasive phenotype by
entering into the host cells where they replicate. For that purpose,
these bacteria manipulate the cytoskeleton for uptake and for di-
rect spreading from one cell to another [80,81]. In this context,
internalization of Y. enterocolitica appeared to be facilitated by
the hemichannel function of Cx43 when expressed in HeLa cells
[82].
The mechanisms underlining S. ﬂexneri invasion of intestinal
cells are more documented and prove to inﬂuence two stages of
the process: the contact between the bacteria and the cells before
the uptake, and the spreading of internalized bacteria from cell to
cell. Romero and colleagues showed that S. ﬂexneri is captured via
thin ﬁlopodia protruding out of the intestinal epithelial cells [83].
These structures, called ‘‘nanometer-thin micropodial extensions
(NME)’’, retract upon attachment with the bacteria, bringing them
in close contact with the entry site located near the point of ﬁlopo-
dia retraction on the cell body. Interestingly, the authors showed
that ATP release through Cx26 hemichannels contributed to the
control of actin polymerization within NMEs in Cx26-expressing
HeLa cells [83]. This mechanism may represent a mean for bacteria
to avoid activating the host innate immunity by escaping from
extracellular PPRs.
Upon its internalization, S. ﬂexneri spreads between cells via
host membrane protrusions formed by modiﬁcations of actin poly-
merization. The number of foci of actin polymerization in cell cul-
tures and the number of bacteria spreading from one cell to
another were monitored by microscopy in the Caco2/TC7 intestinal
cell line and were both found to be increased by an ATP-dependant
release via Cx hemichannels, as assessed by gap junction pharma-
cological blockers [84]. Using blocking antibodies directed against
conserved extracellular domains of Cx26, Cx32 and Cx43, hemi-
channels formed by these Cxs were mostly localized at the basolat-
eral membrane of polarized Caco2/TC7 cells, and speciﬁcally
implicated in ATP exit during S. ﬂexneri infection [85]. Of note,
Simpson and colleagues also conﬁrmed that cellular invasion of
S. ﬂexneri was decreased in Caco2/TC7 cells knockdown for Cx26
[86]. Finally, the speciﬁcity of these Cxs, among others, in support-
ing S. ﬂexneri invasion was evaluated by Man and colleagues in
HeLa cells exogenously expressing Cx26, Cx30 or Cx31 [87]. The
expression of Cx26 markedly enhanced bacterial invasion while
Cx30 and Cx31 had no effect. Of note, in the same study, HeLa cells
expressing (R143W) Cx26, a deafness-associated mutant form
characterized by impaired Cx26 channel activity [88,89], were
tested as well, and did not show any enhancement of bacterial
invasion, conﬁrming the involvement of Cx26 in S. ﬂexneri infection
[87].
In contrast with S. ﬂexneri, the diarrhea-causing EPEC is a mod-
erately invasive pathogen. It must adhere to the target intestinal
epithelial cells and then alter cell functions to induce pathogeny
[90]. A recent study reported that overexpression of Cx26 in HeLa
cells contributed to EPEC adhesion [86]. A signiﬁcant reduction inEPEC adherence was observed in HeLa cells expressing the mutant
R143W compared with wild-type Cx26. In the same study, similar
reduction in EPEC adherence was observed in an intestinal cell line
treated with interference RNA against Cx26 compared to controls.
These in vitro results suggest an implication of Cx26 in the control
of bacterial adhesion to the target cells by yet unknown
mechanisms.
Interestingly, these implications of Cx26 in gastrointestinal
infection may explain how the R143WCx26 mutation, previously
reported as a common African population-speciﬁc recessive muta-
tions associated to deafness [91], could provide a heterozygous
advantage in developing countries where gastrointestinal infec-
tions are more severe [87].
6.4. S. ﬂexneri-induced dampening of endogenous danger signaling
ATP release through Cxs hemichannels is an important event for
invasion of intestinal epithelial cells. However, marked rises in the
concentration of extracellular ATP is also a well-known endoge-
nous danger signal that triggers a protective inﬂammatory host re-
sponse [92]. In this context, S. ﬂexneri has developed counteracting
mechanisms for inhibiting ATP release once internalized. Indeed,
Puhar and colleagues recently demonstrated that the S. ﬂexneri
effector IpgD is very rapidly injected into epithelial intestinal cells
during invasion [79]. IpgD, which acts as a phosphatidylinositol
4,5-bisphosphate (PtdIns(4,5)P2) 4-phosphatase, yielding the rare
product PtdIns5P [93], was found to directly inhibit ATP secretion
by Cx hemichannels. Similar effects of S. ﬂexneri-induced IpgD on
inhibition of ATP release was found in HeLa cells expressing
Cx26. Finally, using a rabbit model of intestine infection allowing
extracellular ATP measurement, the authors showed enhanced
ATP exit from IpgD-deﬁcient S. ﬂexneri-infected colonic tissues
accompanied by severe inﬂammation and subsequent tissue dam-
age [79]. Of note, Puhar and colleagues also reported that S. ﬂexneri
induces a brief ATP release before it is inhibited by IpgD. It is
tempting to speculate how this early and transient increase of
extracellular ATP would be sufﬁcient for the bacteria to sustain
their invasion via ATP- and Cx-dependent mechanisms, as dis-
cussed above [83,84], just before it serves as an endogenous danger
signal.
6.5. Horizontal intestinal epithelial cell activation in response to S.
ﬂexneri
Another mechanism for S. ﬂexneri to evade the inﬂammatory re-
sponse triggered by its host involves the secretion of effector pro-
teins such as Outer Surface Proteins OspF and OspG. These
bacterial products are able to inhibit NF-jb and MAPKs, which col-
lectively promote IL-8 mediated inﬂammation [94–96]. In this con-
text, gap junctions have been involved in the host strategy to ﬁght
back this evasion mechanism. Indeed, Kasper and colleagues dem-
onstrated, in the well coupled Caco-2 intestinal cells, that IL-8 was
detectable in bystander cells around those that internalized S. ﬂex-
neri [97]. Similar effects were observed with the invasive Listeria
monocytogenes and S. Typhimurium. Since these bacteria inhibited
IL-8 response in infected cells, i.e. cells that internalized the bacte-
ria, the release of IL-8 by bystander cells allowed the onset of an
inﬂammatory response at the vicinity of the site of infection. Inter-
estingly, gap junctions were found necessary for cell-to-cell diffu-
sion of signals that activated NF-jB, ERK, JNK and p38 kinases.
Although dependent on NLR activation in infected cells, the nature
of the exchanged signals between cells was, however, not eluci-
dated. On the other hand, Dolowschiak and colleagues investigated
the indirect epithelial activation of intestinal cells infected with L.
monocytogenes in vitro, by monitoring the synthesis of the chemo-
kine CXCLl-2. They found horizontal epithelial activation that was
AB
Fig. 1. Putative roles of connexins in host–pathogen interactions during infection of airway epithelial cells with P. aeruginosa (A) and of intestinal epithelial cells with S.
ﬂexneri (B). (A) Recognition of P. aeruginosa glycoproteins by TLR2 triggers Ca2+ waves in epithelial cells that spread to neighboring cells, activating NF-jB, transcription and
release of IL-8, a key chemokine for neutrophil-dominated inﬂammation. Recognition of P. aeruginosa lipopolysaccharide (LPS) by TLR4 may dampen inﬂammation by
reducing Cx43 expression and/or activity. Recognition of P. aeruginosa ﬂagellin by TLR5 activates MAPKs, which through multiple regulatory mechanisms enhance the
functional expression of Cx43. Enhanced GJIC favors the spread of pro-apoptotic signals to neighboring cells. Apoptosis is accompanied by ATP release, possibly through Panx1
channels, which may contribute to the immune response by attracting phagocytic cells at the site of infection. (B) S. ﬂexneri-induced ATP release through Cx hemichannels
activates purinergic receptors to trigger outward Cl- transport and abrupt water secretion, leading to diarrhea. Purinergic intracellular signaling also leads to actin
polymerization at NME as well as at the cell membrane to facilitate S. ﬂexneri uptake and horizontal infection through cellular protrusions, respectively. Upon direct contact
with the cell membrane, S. ﬂexneri injects IpgD, OspF and OspG into the infected cell. IpgD inhibits ATP release through Cx hemichannels, possibly to dampen release of the
danger signal. OspF and OspG silence the inﬂammatory response by inhibiting NLR-dependent activation of NF-jB and MAPKs. On the other hand, NLR-dependent signals are
transferred via gap junctions to bystander cells. This mechanism activates, in neighboring cells, NF-jB and MAPKs, leading to IL-8-mediated inﬂammation in the vicinity of
infected cells. See text for details and references.
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tors, but that relied on the diffusion of reactive oxygen intermedi-
ates synthesized upon infection [98]. Thus, gap junction-
dependent and gap junction-independent mechanisms of horizon-
tal epithelial activation of the immune response exist and may be
complementary in counteracting bacterial evasion of the inﬂam-
matory defense.
6.6. Commensal-mediated intestinal barrier protection
Commensal bacteria live in symbiosis with the host in resting
conditions, and the maintenance of mucosal immunity via PRRs
is ﬁnely tuned to keep a balance between the microbiota and
invading pathogens. In this context, TLR2 activation by commensal
bacteria plays a key role in maintaining functional barrier integrity
of the intestinal epithelium by suppressing inﬂammation, estab-
lishing tolerance and promoting healing in the presence of mucosal
lesion [99]. Ey and colleagues identiﬁed a physiological function of
TLR2 in the intestinal epithelial barrier maintenance via induction
of Cx43 at the transcriptional and post-translational levels [100].
Consistent with this, the activation of TLR2 by its synthetic ligand
PCSK was found protective in a chronic model of colitis using
MDR1a/ mice by inhibition of gap junction disruption. The
authors also showed that decreased expression of Cx43 in rectal
epithelial cells via local RNA interference treatment inhibited the
protective role of PCSK against ulcers [100]. Approximately 3–
10% of Caucasians are heterozygous for the TLR2 polymorphism
R753Q, which has recently been associated with severe ulcerative
colitis in patients [101]. Interestingly, this polymorphism, when
expressed in an intestinal epithelial cell line, activated the prote-
asomal pathway leading to excessive Cx43 degradation, thereby
impairing TLR2-dependent GJIC. Collectively, these results indicate
that Cx43 deﬁciency results in a defect of TLR2-mediated protec-
tion during intestinal injury, suggesting Cx43 exerts a protective
role upon TLR2 activation by commensal bacteria in a prophylactic
manner in order to heal inﬂammation-caused injuries.
7. Concluding remarks and perspectives
GJIC coordinates cellular functions essential for sustaining tis-
sue homeostasis but their regulation and contribution in mucosal
defenses are not well understood. The roles of Cxs in host–patho-
gen interactions reviewed here proved to be either beneﬁcial or
detrimental during infection, depending on the tissue and the bac-
terium (Fig. 1). Cxs (and Panxs) are implicated in defense mecha-
nisms such as mucociliary clearance and production of surfactant
in the lung, or maintenance of barrier integrity in the intestine.
The ability of gap junctions to spread signals between cells was
found critical to mobilize bystander cells to mount an inﬂamma-
tory response following bacterial infection. Interestingly, regula-
tion of gap junction channel activity by pro-inﬂammatory
molecules also appeared to modulate the strength of inﬂammation,
which may avoid unnecessary tissue damage. Finally, apoptosis, a
process involved in bacterial clearing, required functional gap
junctions. Conversely, pathogens can target gap junctions for
destruction but use connexon-mediated ATP release to favor their
adhesion, invasion and cell-to-cell spreading, as observed for S.
ﬂexneri in the intestine. One could notice from the studies reported
here that gap junctions mediate protective mechanisms against
infection in mucosae, while connexons are more ambivalent. It is
worth to note that hemichannel activity has been found to be
upregulated by PAMPs in condition in which GJIC was reduced
[102,103]. These results suggest an intimate balance between
connexon and gap junction activities of a given Cx type upon path-
ogen recognition, which may be manipulated by pathogens tofacilitate host colonization and to contribute to the development
of associated diseases.
An additional level of complexity is brought by the existence of
Panxs, which are expected to be involved in mucosal defense.
These facts may, at ﬁrst glance, discourage from targeting Cxs
and Panxs in prophylaxis and therapy of human bacteria-induced
diseases. However, some pharmacological compounds affecting
Cxs and Panxs are already used as therapeutic drugs with minimal
side effects like for example, Probenecid, a Panx1 channel blocker,
used as a gout remedy [13]. There is also much hope for develop-
ment of efﬁcient RNA interference nucleotides and/or mimetic
blocking peptides to target key steps in host–pathogen interac-
tions. Alternatively, the development of strategies to modulate
speciﬁc molecules that mediate the regulation of GJIC may be pro-
ven to be beneﬁcial. In the case of chronic infectious diseases, mic-
robiota therapies, with the aim of restoring a protective ﬂora, may
reveal hitherto unexpected consequences on gap junction func-
tions [20].
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